Navigation Links
French Lifestyle Secret Finally Revealed: Lycotec Publishes Unexpected Findings on Roquefort Cheese

CAMBRIDGE, England, Dec. 11, 2012 /PRNewswire/ -- The Lycotec team has recently started to publish its findings on the French cheese, Roquefort, in "Could cheese be the missing piece in the French paradox puzzle?" Unexpected anti-inflammatory factors discovered in this blue-vein cheese could lead to the development of a new generation of pharmaceuticals and future cosmetic products.

In this first publication, the authors Dr. Ivan Petyaev and Dr. Yuriy Bashmakov suggest that regular consumption of Roquefort, Camembert and other moulded fermented cheeses could be the answer to some of today's key health problems. Despite a diet high in saturated fats, France has been known to have the lowest rate of cardiovascular mortality. Today, the real secret to this lifestyle has been revealed. Eat more mouldy cheese!

Extensive laboratory and clinical validation by the Lycotec doctors and scientists have demonstrated that these anti-inflammatory factors, which occur during the ripening of the cheese, have unique properties which work best in acidic environments. The most notable two environments affected by these smelly cheeses include the stomach lining and skin surface.

In fact, the anti-inflammatory factors found in these cheeses could be extracted and used independently or as a part of today's pharmaceutical or beauty products. Moreover, there is a growing consensus that sub-clinical inflammation is behind many aging processes, from the loss of skeletal muscles and cellulite to metabolic, cardiovascular and cerebrovascular diseases.

The Lycotec Team urges pharmaceutical and beauty product companies to take a look at this new publication for future product ideas and partnerships, without the mouldy smell.

About the Lycotec Team:

Based in Cambridge, Lycotec focuses on the development and commercialisation of its proprietary bio-medical technologies for pharmaceutical, nutraceutical and functional food industries.

For more information please contact info(at)lycotec(dot)com

Media Contact:
Ivan Petyaev


SOURCE Lycotec
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil
2. Pycnogenol® (French Maritime Pine Bark Extract) Shown To Improve Endothelial Function And Reduce Oxidative Stress In New Clinical Trial
3. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
4. Cardinal Health Honored With Best Employers for Healthy Lifestyles Award by National Business Group on Health
5. Data Underscore Promise of Satori Pharmaceuticals Gamma-Secretase Modulator Program in Treatment of Alzheimers Disease
6. Satori Pharmaceuticals to Present Data Highlighting Promise of Gamma-Secretase Modulators in Treatment of Alzheimers Disease
7. Total Therapeutic Management, Inc. invites directors of quality improvement to learn secrets of provider engagement strategies
8. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
9. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
10. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
11. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
Post Your Comments:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):